Search Results - "Saïagh, Soraya"
-
1
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
Published in Journal of translational medicine (16-05-2011)“…Adoptive cell therapy (ACT) has emerged as an effective treatment for patients with metastatic melanoma. However, there are several logistical and safety…”
Get full text
Journal Article -
2
Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients
Published in Transplantation (01-04-2021)“…BACKGROUND:Kidney transplantation is the therapeutic of choice for patients suffering from kidney failure. Whilst immunosuppressive drugs can control graft…”
Get full text
Journal Article -
3
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial
Published in Cancer Immunology, Immunotherapy (01-08-2020)“…Background Adoptive tumor-infiltrating lymphocytes (TIL) therapy and interleukin-2 (IL-2) have been investigated in melanoma. Aim To confirm previously…”
Get full text
Journal Article -
4
Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy
Published in PloS one (24-07-2013)“…Fetal skin heals rapidly without scar formation early in gestation, conferring to fetal skin cells a high and unique potential for tissue regeneration and scar…”
Get full text
Journal Article -
5
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial
Published in Acta oncologica (07-11-2024)“…I the proliferation of intra-tumour CD8+ T cells is directly correlated with the clinical response, making tumour-infiltrating lymphocytes (TILs) a treatment…”
Get full text
Journal Article -
6
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients
Published in Kidney international (01-03-2023)“…Kidney transplant survival is shortened by chronic rejection and side effects of standard immunosuppressive drugs. Cell-based immunotherapy with tolerogenic…”
Get more information
Journal Article -
7
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
Published in Cancer Immunology, Immunotherapy (01-10-2021)“…Adoptive cell transfer (ACT) of tumor-specific T lymphocytes represents a relevant therapeutic strategy to treat metastatic melanoma patients. Ideal T-cells…”
Get full text
Journal Article -
8
CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial
Published in Current controlled trials in cardiovascular medicine (28-10-2019)“…Wound repair is one of the most complex biological processes of human life. Allogeneic cell-based engineered skin substitutes provide off-the-shelf temporary…”
Get full text
Journal Article -
9
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
Published in Journal of immunology research (01-01-2018)“…Immunotherapy for melanoma includes adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TILs). This monocenter retrospective study was…”
Get full text
Journal Article -
10
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients
Published in Human vaccines & immunotherapeutics (03-10-2021)“…This was a phase I/II study testing the feasibility of a vaccine by autologous leukemic apoptotic corpse-pulsed dendritic cells (DC) in elderly acute myeloid…”
Get full text
Journal Article -
11
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study
Published in Journal of immunotherapy (1997) (01-04-2014)“…We report herein the results we obtained and the limitations we experienced during the production and use of a bank of Epstein-Barr virus (EBV)-transformed…”
Get full text
Journal Article -
12
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones
Published in Journal of investigative dermatology (01-12-2009)“…Immunotherapy by adoptive T-cell transfer aims at maximizing tumor antigen-specific T-cell responses. We treated 14 patients at the metastatic stage in a phase…”
Get full text
Journal Article -
13
The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations
Published in Cytotherapy (Oxford, England) (01-03-2018)“…Abstract Background aims To produce an anti-leukemic effect after hematopoietic stem cell transplantation we have long considered the theoretical possibility…”
Get full text
Journal Article -
14
Preclinical assessment of Autologous Tolerogenic Dendritic Cells from End-stage renal disease patients
Published in Transplantation (15-05-2020)Get full text
Journal Article -
15
Tissue biomarkers in melanoma patients treated with TIL
Published in PloS one (20-12-2012)“…While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on…”
Get full text
Journal Article -
16
Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product
Published in Journal of immunological methods (30-09-2007)“…gamma9delta2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also…”
Get full text
Journal Article -
17
New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance
Published in Laboratory investigation (01-10-2013)Get full text
Journal Article -
18
Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS “TCR γ/δ + T cell isolation kit”
Published in Journal of immunological methods (15-08-2009)“…Interest in γ9δ2 T cells has increased greatly in the past decade. While several protocols allowed the amplification of a large proportion of these cells in…”
Get full text
Journal Article -
19
Large scale expansion of γ9δ2 T lymphocytes: Innacell γδ™ cell therapy product
Published in Journal of immunological methods (30-09-2007)“…γ9δ2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also secrete…”
Get full text
Journal Article -
20
265.3: Advancing CD8+ Treg cell therapy to the clinic for the treatment of kidney transplanted patients
Published in Transplantation (01-09-2024)Get full text
Journal Article